Show results for
Refine by
Destiny Pharma Methicillin Resistant Staphylococcus Aureus Equipment & Supplies In Mauritius
3 equipment items found
Manufactured by:Destiny Pharma plc based inBrighton, UNITED KINGDOM
A Phase 2b clinical study, which was a multi-centre, randomized, placebo-controlled study of XF-73 nasal gel as a new product for the prevention of the incidence of post-surgical infections such as methicillin-resistant Staphylococcus aureus (MRSA) completed recruitment at the end of 2020 and top-line results were reported in Q1 ...
Manufactured by:Destiny Pharma plc based inBrighton, UNITED KINGDOM
There are two XF-73 dermal programmes in development. One is being run by our China partner and shareholder – China Medical Systems Holdings Limited (CMS) – focused on superficial skin infections and the other is an in-house programme looking at the use of XF-73 for the prevention and treatment of serious infections associated with burns and open wounds such as diabetic foot ulcers ...
Manufactured by:Destiny Pharma plc based inBrighton, UNITED KINGDOM
The XF drug platform has a novel, ultra-rapid mechanism that reduces the chance of bacteria becoming resistant to its action. Destiny Pharma’s XF platform has advantages over traditional antibiotics. ...